Current
13.6×
5-Year Average
8.2×
All-Time High
14.1×
All-Time Low
-1.9×
EV/EBITDA daily chart for Molina Healthcare (MOH)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical EV/EBITDA for Molina Healthcare (MOH) from 2003 to 2025
| 2025 | $8.81B | $976.00M | 8.7× | +3.0× | |
| 2024 | $16.71B | $1.89B | 5.7× | -2.4× | |
| 2023 | $20.96B | $1.74B | 8.2× | -2.2× | |
| 2022 | $19.15B | $1.35B | 10.4× | -1.3× | |
| 2021 | $18.45B | $1.13B | 11.7× | +4.0× | |
| 2020 | $12.61B | $1.15B | 7.8× | +3.0× | |
| 2019 | $8.41B | $1.15B | 4.8× | +1.4× | |
| 2018 | $7.21B | $1.24B | 3.4× | — | |
| 2017 | $4.38B | −$316.00M | — | — | |
| 2016 | $3.00B | $465.00M | 0.1× | -1.5× | |
| 2015 | $3.37B | $514.62M | 1.6× | -1.3× | |
| 2014 | $2.62B | $326.52M | 2.9× | -0.3× | |
| 2013 | $1.59B | $227.08M | 3.2× | -0.6× | |
| 2012 | $1.26B | $99.97M | 3.9× | +0.9× | |
| 2011 | $1.03B | $140.73M | 2.9× | +1.2× | |
| 2010 | $842.84M | $165.77M | 1.7× | +0.4× | |
| 2009 | $584.10M | $95.24M | 1.3× | +0.7× | |
| 2008 | $467.19M | $146.70M | 0.6× | -4.4× | |
| 2007 | $1.10B | $125.51M | 5.0× | +0.1× | |
| 2006 | $911.51M | $97.29M | 4.8× | -1.6× | |
| 2005 | $739.74M | $59.97M | 6.5× | -3.5× | |
| 2004 | $1.28B | $96.43M | 10.0× | +9.0× | |
| 2003 | $638.45M | $416.94M | 1.0× | — |
- 20258.7×
- 20245.7×
- 20238.2×
- 202210.4×
- 202111.7×
- 20207.8×
- 20194.8×
- 20183.4×
- 2017—
- 20160.1×
- 20151.6×
- 20142.9×
- 20133.2×
- 20123.9×
- 20112.9×
- 20101.7×
- 20091.3×
- 20080.6×
- 20075.0×
- 20064.8×
- 20056.5×
- 200410.0×
- 20031.0×
About EV/EBITDA at Molina Healthcare (MOH)
Molina Healthcare (MOH) EV/EBITDA ratio is 13.6× as of June 5, 2026. The 5-year average is 8.2×. The sector median currently stands at 15.0×. The current ratio is at the 99th percentile of its own 10-year history.
Molina Healthcare (MOH) historical EV/EBITDA ratio has ranged from a low of -1.9× (2017) to a high of 14.1× (2026) in the available daily series.
The EV/EBITDA ratio (the enterprise multiple) compares enterprise value (EV) to trailing twelve-month (TTM) EBITDA. EV is calculated as market capitalisation + total debt − cash & short-term investments. Because EV/EBITDA is capital-structure-neutral and ignores non-cash depreciation and amortisation, it is the standard multiple used in M&A and for cross-company or cross-border comparisons. Note: this calculation uses a simplified EV (minority interest and preferred equity excluded due to data availability), consistent with most public financial-data providers.
Molina Healthcare EV/EBITDA by Year
Molina Healthcare EV/EBITDA 2025: 8.7×
Molina Healthcare (MOH) EV/EBITDA ratio in 2025 was 8.7×, expanded from 5.7× the prior year.
Molina Healthcare EV/EBITDA 2024: 5.7×
Molina Healthcare (MOH) EV/EBITDA ratio in 2024 was 5.7×, contracted from 8.2× the prior year.
Molina Healthcare EV/EBITDA 2023: 8.2×
Molina Healthcare (MOH) EV/EBITDA ratio in 2023 was 8.2×, contracted from 10.4× the prior year.
Molina Healthcare EV/EBITDA 2022: 10.4×
Molina Healthcare (MOH) EV/EBITDA ratio in 2022 was 10.4×, contracted from 11.7× the prior year.
Molina Healthcare EV/EBITDA 2021: 11.7×
Molina Healthcare (MOH) EV/EBITDA ratio in 2021 was 11.7×.
EV is calculated as Market Cap + Total Debt − Cash & Short-Term Investments (simplified). Minority interest and preferred equity are excluded due to data availability. This is consistent with the methodology used by most public financial data providers.
Sector peers by EV/EBITDA — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by EV/EBITDA — table
Healthcare peers of Molina Healthcare (MOH), ranked by EV/EBITDA ratio.
| 14.0× | |
| 13.9× | |
| 13.6× | |
| 13.6× | |
| 13.2× | |
| 12.9× | |
| 12.9× | |
| 12.7× | |
| 12.4× | |
| 12.0× | |
| 11.7× | |
| 11.5× | |
| 11.5× | |
| 11.2× | |
| 10.5× | |
| 10.0× | |
| 8.5× | |
| 8.2× | |
| 7.9× | |
| 7.8× | |
| 6.8× | |
| 6.5× | |
| 5.8× | |
| 5.7× | |
| 4.5× |
- 13.6×
- 13.2×
- 12.9×
- 12.4×
- 12.0×
- 11.7×
- 11.5×
- 10.5×
- 10.0×
- 8.5×
- 8.2×
- 7.9×
- 7.8×
- 5.8×
- 4.5×
Frequently asked questions
Molina Healthcare (MOH) Key Financials
Charts, filings, and peer comparison for every metric